Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

This letter to CMS reiterates AHA’s position that the agency’s Most Favored Nation Proposed Rule should be withdrawn.
AHA responds to the agency’s most recent information collection notice proposing an IRF review choice demonstration (RCD).
The AHA urges congressional leaders to include in year-end legislation provisions to extend the moratorium on Medicare sequester cuts and to prevent the Statutory Pay-As-You-Go Act of 2010 (Statutory PAYGO) sequester from taking effect at the end of this session of Congress.
The U.S. Chamber of Commerce and 21 other organizations, including the AHA, urge Congress to maintain the current legal and regulatory framework for evaluating mergers and acquisitions.
The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services 7500 Security Blvd Baltimore, MD 21244
AHA response to comments on certain product exclusions related to COVID-19.
AHA comments on the Provider Relief Fund (PRF) reporting portal. America’s hospitals and health systems have stepped up in heroic and unprecedented ways to meet the challenges of COVID-19.
AHA, others express support of the 340B federal drug pricing program and strongly encourage Congress to protect the program as they consider broader changes to our nation’s health care system.
AHA comments on the Remanufacturing of Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff.
The AHA comments on the Centers for Medicare & Medicaid Services’ hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2022.